Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PHIBRO ANIMAL HEALTH CORPPAHC · Entity 4671 | Chief Financial Officer | September 13, 2017 | September 16, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PHIBRO ANIMAL HEALTH CORP
Report date September 13, 2017 · Filed September 16, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-09-14 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2017-09-13 · Exercise / conversion · Acquired 15,900 · Balance 15,900 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Row 2 · 2017-09-13 · Sale · Disposed 15,900 · Balance 0 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.30 to $36.65, inclusive. Row 3 · 2017-09-14 · Exercise / conversion · Acquired 6,479 · Balance 6,479 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Row 4 · 2017-09-14 · Sale · Disposed 6,479 · Balance 0 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive. Row 5 · 2017-09-14 · Exercise / conversion · Acquired 33,150 · Balance 33,150 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Row 6 · 2017-09-14 · Sale · Disposed 33,150 · Balance 0 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive. |
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 6,479 |
Reported balance
After 2017-09-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-09-13 · Exercise / conversion · Disposed 15,900 · Balance 6,479 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. |
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 0 |
Reported balance
After 2017-09-14 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-09-14 · Exercise / conversion · Disposed 6,479 · Balance 0 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. |
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 0 |
Reported balance
After 2017-09-14 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-09-14 · Exercise / conversion · Disposed 33,150 · Balance 0 F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.30 to $36.65, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 33,150 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · derivative · entry 9 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 33,150 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 14, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 6,479 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · derivative · entry 8 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,479 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 14, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 33,150 | $36.23 | $1,201,024.50 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · nonDerivative · entry 6 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive. Read SEC document |
| September 14, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 33,150 | $11.83 | $392,164.50 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · nonDerivative · entry 5 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 14, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 6,479 | $36.23 | $234,734.17 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · nonDerivative · entry 4 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive. Read SEC document |
| September 14, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 6,479 | $11.83 | $76,646.57 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · nonDerivative · entry 3 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 13, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 15,900 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · derivative · entry 7 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,479 Underlying: Class A Common Stock · 15,900 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 13, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 15,900 | $36.46 | $579,714.00 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · nonDerivative · entry 2 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.30 to $36.65, inclusive. Read SEC document |
| September 13, 2017 Filed Sep 16, 2017 00:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 15,900 | $11.83 | $188,097.00 |
DisclosureSEC source: 0001144204-17-048335 · v475285_form4.xml · nonDerivative · entry 1 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 10,771 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · derivative · entry 12 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,379 Underlying: Class A Common Stock · 10,771 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 12,270 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · derivative · entry 11 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 12,270 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 10,771 | $36.42 | $392,279.82 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 8 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.65, inclusive. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 10,771 | $11.83 | $127,420.93 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 7 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 12,270 | $36.42 | $446,873.40 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 6 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.65, inclusive. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 12,270 | $11.83 | $145,154.10 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 5 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 9,600 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · derivative · entry 10 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,270 Underlying: Class A Common Stock · 9,600 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 9,600 | $36.26 | $348,096.00 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 4 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.45, inclusive. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 9,600 | $11.83 | $113,568.00 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 3 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 14,623 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · derivative · entry 9 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,870 Underlying: Class A Common Stock · 14,623 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 14,623 | $36.19 | $529,206.37 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 2 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.70, inclusive. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 01:38 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 14,623 | $11.83 | $172,990.09 |
DisclosureSEC source: 0001144204-17-047742 · v475012_form4.xml · nonDerivative · entry 1 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 19,139 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · derivative · entry 13 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,493 Underlying: Class A Common Stock · 19,139 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 3,198 | $36.08 | $115,383.84 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 10 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.15, inclusive. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 3,198 | $11.83 | $37,832.34 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 9 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 15,941 | $35.77 | $570,209.57 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 8 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.95, inclusive. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 15,941 | $11.83 | $188,582.03 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 7 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 5,664 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · derivative · entry 12 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,632 Underlying: Class A Common Stock · 5,664 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 5,664 | $35.05 | $198,523.20 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 6 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.25, inclusive. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 5,664 | $11.83 | $67,005.12 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 5 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Common Stock · Derivative | 5,004 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · derivative · entry 11 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,296 Underlying: Class A Common Stock · 5,004 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 764 | $36.54 | $27,916.56 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 4 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.45 to $36.65, inclusive. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 764 | $11.83 | $9,038.12 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 3 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 4,240 | $35.56 | $150,774.40 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 2 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.15, inclusive. Read SEC document |
| September 05, 2017 Filed Sep 8, 2017 01:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 4,240 | $11.83 | $50,159.20 |
DisclosureSEC source: 0001144204-17-047125 · v474769_4.xml · nonDerivative · entry 1 Johnson Richard G · CIK 0001601338 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.